Schedule 13D ownership disclosure
ADDEX THERAPEUTICS LTD
American Depositary Shares, each representing 120 ordinary shares Ordinary shares · CUSIP: 00654J206
Event date: 2025-06-20
- Filing-level shares
- 18,208,437.00
- Percent of class
- 12.94%
- Timothy Mark DyerReported CIK 0001830908
Shares: 18,208,437.00 · Class: 12.94%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-061660
- Form type
- SCHEDULE 13D/A
- Filer
- Addex Therapeutics Ltd.
- CIK
- CIK 1574232
- Filed
- Jun 23, 2025
- Reporting period
- Jun 20, 2025
- Description
- Schedule 13D beneficial ownership